Financial Performance - The company's operating revenue for Q1 2025 was CNY 1,068,269,308.28, representing a 204.86% increase compared to CNY 350,412,650.24 in the same period last year[5]. - The net profit attributable to shareholders was a loss of CNY 61,810,920.22, an improvement from a loss of CNY 80,934,255.09 year-over-year[5]. - The basic and diluted earnings per share were both negative CNY 0.0715, compared to negative CNY 0.0937 in the same period last year[6]. - The net profit for the first quarter of 2025 was -33,811,892.59 RMB, compared to -78,933,203.12 RMB in the same period of 2024, indicating an improvement[19]. - The total comprehensive income attributable to the parent company was -61,810,920.22 RMB for Q1 2025, compared to -80,934,255.09 RMB in Q1 2024[20]. Cash Flow - The net cash flow from operating activities was negative CNY 12,718,985.41, a decrease of 106.72% compared to a positive cash flow of CNY 189,329,644.15 in the previous year[5]. - Cash inflow from operating activities totaled 1,046,065,695.12 RMB in Q1 2025, down from 1,653,755,620.29 RMB in Q1 2024[22]. - Cash outflow from operating activities was 1,058,784,680.53 RMB in Q1 2025, compared to 1,464,425,976.14 RMB in Q1 2024[22]. - The net cash flow from investing activities was -1,418,199.26 RMB in Q1 2025, compared to 4,913,242.32 RMB in Q1 2024[23]. - The net cash flow from financing activities was -375,462,730.35 RMB in Q1 2025, a decrease from 1,832,589,593.97 RMB in Q1 2024[23]. - The ending cash and cash equivalents balance for Q1 2025 was 3,267,432,042.89 RMB, down from 6,787,580,272.23 RMB in Q1 2024[23]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 27,300,224,641.38, down 3.65% from CNY 28,335,517,502.42 at the end of the previous year[6]. - The total liabilities as of March 31, 2025, were ¥23,572,227,279.00, compared to ¥24,563,689,305.18 as of December 31, 2024, indicating a reduction of approximately 4.0%[15]. - Total current assets as of March 31, 2025, were ¥25,746,432,778.16, down from ¥27,302,127,441.25 as of December 31, 2024, representing a decrease of about 5.7%[14]. - Cash and cash equivalents as of March 31, 2025, were ¥3,332,395,397.19, down from ¥3,766,058,041.00 as of December 31, 2024, a decrease of about 11.5%[13]. - Accounts receivable decreased to ¥24,411,289.04 as of March 31, 2025, from ¥27,649,656.00 as of December 31, 2024, a decline of approximately 11.3%[13]. Operating Costs - Total operating costs for Q1 2025 were ¥1,087,145,269.85, compared to ¥432,782,886.53 in Q1 2024, indicating an increase of about 151.5%[18]. - Operating costs included ¥891,616,078.32 in cost of goods sold for Q1 2025, up from ¥333,753,649.16 in Q1 2024, reflecting a rise of approximately 167.5%[18]. - Financial expenses for Q1 2025 amounted to ¥100,523,299.77, compared to ¥47,745,637.11 in Q1 2024, marking an increase of around 109.7%[18]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 34,342[10]. - Shareholders' equity totaled ¥3,727,997,362.38 as of March 31, 2025, slightly down from ¥3,771,828,197.24 as of December 31, 2024, a decrease of approximately 1.2%[16]. - The equity attributable to shareholders decreased by 2.15% to CNY 2,813,682,647.17 from CNY 2,875,503,227.95 at the end of the last year[6]. Revenue Drivers - The significant increase in operating revenue was primarily due to a higher area of completed housing projects recognized compared to the previous year[7]. - The company reported a decrease in cash flow primarily due to reduced sales collections compared to the same period last year[7].

Profit Forecast - The company expects a total profit of approximately -86,800.80 million yuan for the year 2024, with a net profit attributable to shareholders of -88,465.73 million yuan [2]. - The previous profit forecast estimated a total profit of about -69,700 million yuan and a net profit of -77,500 million yuan, indicating a significant downward revision [4]. - The company reported a total profit of -14,715.49 million yuan and a net profit of -9,324.55 million yuan for the same period last year [6]. Revenue Projections - The operating revenue for 2024 is projected to be around 187,669.45 million yuan, with the revenue after excluding non-core business income estimated at 182,025.79 million yuan [5]. Financial Position - The net assets attributable to the parent company at the end of 2024 are expected to be approximately 1,509.75 million yuan [3]. Credit Impairment - The company adjusted its credit impairment loss from an initial estimate of 12,111 million yuan to 23,269 million yuan, impacting operating profit by approximately 11,158 million yuan [7]. Delisting Risk - The company has been placed under delisting risk warning due to the negative profit forecast [2]. Investor Communication - The company acknowledges the impact of the performance forecast correction on investors and expresses sincere apologies [10]. - The company emphasizes that there are no significant disagreements with the auditing firm regarding the performance forecast correction [8]. Audit Confirmation - The financial data presented is subject to final confirmation in the audited annual report for 2024 [9].

Financial Performance - The company's operating revenue for 2024 was CNY 1,175,401,780.87, a decrease of 15.41% compared to CNY 1,389,601,286.62 in 2023[22] - The net profit attributable to shareholders of the listed company was CNY -14,587,166.58, compared to CNY 61,206,384.07 in the previous year, indicating a significant decline[22] - The net profit after deducting non-recurring gains and losses was CNY -38,089,846.38, down from CNY 37,693,074.00 in 2023[22] - The cash flow from operating activities was CNY 192,778,247.22, a decrease of 22.01% from CNY 247,182,519.46 in the previous year[22] - The total assets at the end of 2024 were CNY 3,524,394,269.57, down 4.61% from CNY 3,694,821,482.47 in 2023[22] - The net assets attributable to shareholders of the listed company decreased by 0.87% to CNY 1,660,506,874.47 from CNY 1,675,094,041.05 in 2023[22] - The basic earnings per share for 2024 was CNY -0.0494, compared to CNY 0.2075 in 2023, indicating a shift to negative earnings[23] - The weighted average return on net assets was -0.87% for 2024, down from 3.67% in the previous year[23] Revenue Breakdown - Pharmaceutical business revenue was ¥790,630,187.56, down 20.54% year-on-year, while medical device revenue increased by 14.57% to ¥82,574,608.46[61] - The commercial operations segment generated revenue of ¥188,341,918.76, a decline of 12.94% year-on-year[61] - The exhibition business reported revenue of ¥70,245,750.09, reflecting a growth of 3.81% year-on-year[61] - Revenue from the digestive system segment was CNY 123.51 million, down 57.55% year-over-year, with a gross margin of 81.89%[104] - Revenue from the respiratory segment was CNY 227.76 million, down 3.12% year-over-year, with a gross margin of 61.90%[104] - Revenue from the anti-infection segment was CNY 183.31 million, down 16.53% year-over-year, with a gross margin of 14.42%[104] Market Trends and Strategy - The medical device market in China is projected to grow from 630 billion RMB in 2015 to 1.88 trillion RMB by 2025, with an annual compound growth rate of 11.5%[36] - The domestic market share of domestic brands in high-value consumables, such as artificial joints, increased by 19 percentage points from the first procurement to the 2024 renewal[36] - The company is advancing its "big health + big business" dual business strategy, emphasizing cost control and efficiency improvement[30] - The company is focusing on innovation and market expansion in response to the structural changes in the pharmaceutical industry, particularly in the demand for innovative drugs[130] Research and Development - The company has published 5 papers and presented 36 academic conference papers during the reporting period, indicating a commitment to research and development[31] - The company has a comprehensive R&D platform, with ongoing clinical trials for its innovative drugs expected to yield results by 2025[58] - The company is conducting Phase II clinical trials for the innovative drug DDCI-01, targeting pulmonary arterial hypertension and benign prostatic hyperplasia[105] - Total R&D investment for the year was CNY 45.09 million, with an expense ratio of 3.84% of revenue[112][115] Operational Developments - The company completed the resumption of production for 19 varieties across 9 production lines, resulting in 13 products being launched and sold during the reporting period[30] - The company is actively promoting the construction of new hospital facilities to enhance patient care environments[31] - The company has opened 3 shopping centers and 1 specialty store in Wuhan, with a total area of 35.37 thousand square meters[84] Governance and Management - The company has established a governance structure that complies with relevant laws and regulations, ensuring equal rights for all shareholders, particularly minority shareholders[147] - The board of directors consists of 9 members, including 3 independent directors, and has established four specialized committees to enhance governance and oversight[148] - The company has implemented measures to avoid potential competition with its controlling shareholder by entering into a management contract for the operation of exhibition venue assets[149] - The company has a total of 44,256,815 shares under the employee stock ownership plan, indicating a commitment to employee engagement and retention[155] Environmental Responsibility - The company has established a mechanism for environmental protection and is classified as a key pollutant discharge unit[189] - The wastewater treatment process includes "high-concentration water regulation, mixed air flotation, hydrolysis acidification, secondary contact oxidation, activated sludge, contact oxidation, flocculation sedimentation, and artificial wetland," ensuring compliance with relevant environmental standards[192] - The company has improved its environmental management system, integrating environmental protection into daily operations and enhancing overall awareness among employees[197] Challenges and Risks - The company acknowledges high risks in R&D innovation, including high costs, long cycles, and low success rates, and plans to enhance risk management strategies to improve success rates in new drug and medical device development[144] - The company is closely monitoring industry policy changes to mitigate operational risks associated with drug production costs and profitability due to reforms in the pharmaceutical and medical device sectors[142]

Financial Performance - The company's operating revenue for Q1 2025 was ¥55,890,050.68, representing a 37.69% increase compared to ¥40,592,181.93 in the same period last year[4] - The net profit attributable to shareholders was -¥10,141,839.58, a decline from -¥8,647,038.09 year-over-year[4] - The basic and diluted earnings per share were both -¥0.0181, compared to -¥0.0155 in the same period last year[4] - Net loss for Q1 2025 was ¥12,378,795.05, compared to a net loss of ¥8,013,135.78 in Q1 2024, indicating a worsening financial performance[20] - The total comprehensive income for the first quarter of 2025 was -12,378,795.05 RMB, compared to -8,013,135.78 RMB in the same period of 2024, indicating a decline[21] Cash Flow - The net cash flow from operating activities was -¥32,712,234.99, significantly lower than -¥336,478.66 in the previous year[4] - The net cash flow from investing activities was -608,381.22 RMB in Q1 2025, compared to -1,001,096.16 RMB in Q1 2024, showing an improvement[23] - The net cash flow from financing activities for Q1 2025 was 29,827,953.19 RMB, a significant increase from -1,287,013.57 RMB in Q1 2024[24] - The total cash outflow from operating activities was 116,282,269.53 RMB in Q1 2025, compared to 52,354,475.49 RMB in Q1 2024, indicating a substantial increase in cash expenditures[23] - Cash received from sales of goods and services increased to 59,850,081.41 RMB in Q1 2025, up from 47,080,421.46 RMB in Q1 2024, reflecting a growth of approximately 27%[22] - The company reported a significant increase in cash received from other operating activities, which rose to 23,716,856.82 RMB in Q1 2025 from 4,937,437.74 RMB in Q1 2024[23] Assets and Liabilities - Total assets at the end of the reporting period were ¥360,911,172.81, an increase of 7.32% from ¥336,309,774.52 at the end of the previous year[5] - Current assets totaled ¥218,457,851.50 as of March 31, 2025, up from ¥197,052,223.45 at the end of 2024, reflecting improved liquidity[14] - The company's total liabilities increased to ¥274,488,757.43 as of March 31, 2025, from ¥239,008,564.09 at the end of 2024[16] - Short-term borrowings rose significantly to ¥21,012,466.67 in Q1 2025, compared to ¥10,011,611.11 in Q4 2024, indicating increased leverage[15] Shareholder Equity - The equity attributable to shareholders decreased by 13.27% to ¥66,263,365.12 from ¥76,405,204.70[5] - The total equity attributable to shareholders decreased to ¥66,263,365.12 as of March 31, 2025, from ¥76,405,204.70 at the end of 2024, indicating a decline in shareholder value[16] - The weighted average return on equity was -14.22%, a decrease of 7.88 percentage points from -6.34%[4] - The total number of common shareholders at the end of the reporting period was 31,300[10] Operating Costs and Revenue Sources - Total operating costs for Q1 2025 were ¥67,576,281.23, up 37.2% from ¥49,214,947.42 in Q1 2024[19] - The increase in operating revenue was primarily due to higher income from short dramas and post-production services[7] - The company reported non-operating income and expenses totaling -¥326,997.62 for the period[6] - Research and development expenses for Q1 2025 were ¥12,254,099.84, down from ¥16,252,041.34 in Q1 2024, suggesting a potential shift in focus or budget allocation[20] - The company reported a significant increase in accounts receivable, which rose to ¥26,310,772.46 as of March 31, 2025, from ¥22,049,698.50 at the end of 2024[14] Cash and Cash Equivalents - The total cash and cash equivalents at the end of Q1 2025 were 54,293,872.17 RMB, down from 76,886,515.95 RMB at the end of Q1 2024[24] - The company received 1,500,000.00 RMB from investment in Q1 2025, marking a new inflow compared to the previous year[24]

Financial Performance - The company's operating revenue for 2024 reached ¥3,214,641,144.79, representing a 13.68% increase compared to ¥2,827,845,131.92 in 2023[23]. - Net profit attributable to shareholders for 2024 was ¥235,731,377.54, a 3.99% increase from ¥226,691,675.96 in 2023[23]. - The net profit after deducting non-recurring gains and losses was ¥189,815,225.44, showing a slight decrease of 1.92% from ¥193,530,052.56 in 2023[23]. - The company's total assets increased by 5.09% to ¥11,383,215,736.10 at the end of 2024, up from ¥10,831,375,831.70 in 2023[24]. - The net assets attributable to shareholders rose by 3.90% to ¥4,566,438,106.75 at the end of 2024, compared to ¥4,395,059,137.20 in 2023[24]. - Basic earnings per share for 2024 were ¥0.1913, a 3.97% increase from ¥0.1840 in 2023[25]. - The cash flow from operating activities for 2024 was ¥468,616,948.27, down 31.20% from ¥681,110,647.22 in 2023[23]. - In the fourth quarter of 2024, the company reported a net profit attributable to shareholders of -¥4,504,070.06, contrasting with profits in the previous three quarters[27]. - The company recorded non-recurring gains of ¥30,857,645.52 from government subsidies closely related to its normal business operations in 2024[29]. Dividend and Share Capital - The company plans to distribute a cash dividend of 0.57 RMB per 10 shares, totaling 71,914,448.66 RMB for the current year[4]. - The total share capital of the company is 1,261,656,994 shares[4]. - The company does not plan to increase capital reserves through stock issuance this year[4]. - The cash dividend amount represents 30.51% of the net profit attributable to ordinary shareholders in the consolidated financial statements, which is CNY 235.73 million[178]. - Over the last three accounting years, the cumulative cash dividend amount (including tax) is CNY 201.66 million, with a cash dividend ratio of 95.82% based on the average annual net profit of CNY 210.45 million[179]. Audit and Compliance - The company has received a standard unqualified audit report from the accounting firm Xin Yong Zhong He[3]. - The board of directors has ensured the accuracy and completeness of the annual report[3]. - There are no violations of decision-making procedures for external guarantees[6]. - The company has not faced any risks that would prevent a majority of directors from ensuring the authenticity of the annual report[7]. - The company has not reported any absence of directors that would affect the annual report's integrity[7]. - The company has established a comprehensive internal control system to enhance risk prevention capabilities, following relevant guidelines and standards[139]. - The internal control system is deemed effective, with no significant deficiencies reported during the evaluation period[184]. - The company has not faced any regulatory criticisms or penalties related to information disclosure during the reporting period[135]. Risk Management - The company has outlined potential risks in its management discussion and analysis section[7]. - The company established a comprehensive risk management framework, completing 242 internal regulations and revising 78 throughout the year[43]. - The company recognizes the risk of policy changes affecting pricing and regulatory frameworks in the water, electricity, and gas sectors[126]. - The company faces natural disaster risks that could impact hydropower and distributed photovoltaic generation due to extreme weather conditions[126]. - The company reported accounts receivable of 604.83 million yuan, representing 28.45% of current assets and 18.81% of revenue, indicating potential bad debt risks[127]. Operational Highlights - The water sales volume reached 99.4941 million cubic meters, an increase of 11.34% compared to the previous year[38]. - The total installed capacity of distributed photovoltaic reached 172.02 MW, with an addition of 126.04 MW during the year[38]. - The company completed 20 infrastructure projects and successfully put 4 major projects into operation[39]. - The annual power generation of Xinjiang Aizhong Energy reached 708.79 million kWh, setting a new historical record[40]. - The company achieved value-added service revenue of RMB 10.71 million in 2024[42]. - The company’s maximum power load reached 718,000 kW, and the maximum daily water supply was 411,400 tons[39]. Environmental and Social Responsibility - The company invested 8.54 million CNY in environmental protection during the reporting period[185]. - The total discharge of Chemical Oxygen Demand (CODcr) for 2024 was 96.02 tons, well below the annual limit of 438 tons[187]. - The company has established a mechanism for environmental protection and complies with relevant environmental regulations[186]. - The company has not faced any administrative penalties due to environmental issues during the reporting period[192]. - The total investment in poverty alleviation and rural revitalization projects amounted to 100.9414 million yuan, benefiting 523,000 people[198]. - The company made a total donation of 120,500 yuan to various public welfare projects, benefiting 409 individuals[198]. Corporate Governance - The company strictly adhered to the regulations of the Shanghai Stock Exchange and maintained a high level of corporate governance, with no violations reported during the period[135]. - The board of directors and supervisory board effectively supervised the company's operations, ensuring compliance and risk management[134]. - The company has established specialized committees within the board to enhance governance and oversight[160]. - The company is focused on improving its internal control and risk management systems as part of its strategic objectives[161]. - The company held three performance briefings during the reporting period, responding to 127 investor inquiries through the Shanghai Stock Exchange's "E Interaction" platform[136]. Employee and Compensation - The total number of employees in the parent company is 222, while the main subsidiaries employ 2,130, resulting in a total of 2,352 employees[166]. - The company has 1,031 retired employees for whom it bears expenses[166]. - The total compensation for the chairman, Yu Zhengjun, during the reporting period was 772,600 CNY[143]. - The total compensation for the general manager was 679,300 CNY[143]. - The total compensation for the independent director, Li Guangjin, was 67,500 CNY[143]. - The total compensation for the supervisor, Zhang Qing, was 633,000 CNY[143]. - The company plans to implement a diversified compensation system, including fixed and variable salary structures, to align employee compensation with organizational and individual performance[168]. - The training plan for 2024 includes 61 offline training sessions and 1,814 participants in online learning, totaling 13,621.28 hours of study[169]. Strategic Initiatives - The company is focusing on the development of distributed photovoltaic projects as a key growth driver, particularly in related industries[123]. - The company plans to leverage external capital and government resources to build industry funds and invest in industrial parks[124]. - The company aims to enhance customer satisfaction and stability through improved service capabilities and effective risk management strategies[126]. - The company plans to expand its market presence and enhance its operational strategies for 2025[165]. - The company is committed to integrating public utilities and providing green low-carbon comprehensive energy services, aiming to enhance market value and profitability[121].

Financial Performance - The company's operating revenue for 2024 is CNY 10,743,433,252.57, a decrease of 6.79% compared to CNY 11,525,976,963.46 in 2023[20] - The net profit attributable to shareholders of the listed company for 2024 is -CNY 1,019,943,835.99, compared to -CNY 390,388,594.01 in 2023, indicating a significant loss[20] - The cash flow from operating activities for 2024 is -CNY 869,737,812.77, a decrease of 185.11% from CNY 1,021,864,607.65 in 2023[21] - The total assets at the end of 2024 amount to CNY 28,335,517,502.42, down 19.73% from CNY 35,299,190,495.98 at the end of 2023[21] - The company's net assets attributable to shareholders decreased by 26.18% to CNY 2,875,503,227.95 in 2024 from CNY 3,895,473,501.00 in 2023[21] - The basic earnings per share for 2024 is -CNY 1.1803, compared to -CNY 0.4518 in 2023, indicating a worsening performance[22] - The weighted average return on net assets for 2024 is -30.13%, a decrease of 20.70 percentage points from 2023[22] - The company plans not to distribute profits or issue bonus shares for the 2024 fiscal year[4] Revenue and Sales - The company achieved a sales revenue of 10.74 billion RMB, a decrease of 6.79% compared to the previous year[41] - The company achieved operating revenue of 8.15 billion RMB in Q4 2024, with a total annual revenue of approximately 10.88 billion RMB[27] - The revenue from transferred areas amounted to 369,939.26 million RMB, with a significant contribution from the project "永安华府" which had a transfer area of 158,126.17 square meters[69] - The recognized revenue from real estate business amounted to RMB 10,607.97 million, with a transfer area of 639,348.43 square meters, and the remaining area to be transferred at the end of the reporting period was 243,662.91 square meters[70] Cost and Expenses - The gross profit margin for the main business in the reporting period is 13.97%[22] - The total cost of goods sold in the real estate sector was ¥9,125,621,910.71, accounting for 98.35% of total costs, which decreased by 6.80% from the previous year[48] - Sales expenses increased by 16.04% to ¥280,837,868.66, primarily due to higher project agency fees compared to the previous year[56] - Financial expenses rose significantly by 67.80% to ¥153,721,231.20, mainly due to increased interest expenses recognized in the current period[57] Investments and Acquisitions - The company completed the acquisition of a 54% stake in Xi'an Jiaxing Real Estate Development Co., Ltd., leading to a reduction in the consolidation scope of the West Xi'an Tianxia Enterprise Management Consulting Partnership[49] - The company increased its stake in Qidian Jinyuan Real Estate Development Co., Ltd. from 49% to 51.43%, expanding its consolidation scope[50] - The company divested from several subsidiaries, including Xi'an Tianziyuan Property Service Management Co., Ltd., reducing its consolidation scope[51] - The company reported a loss of RMB 166.61 million from investments in joint ventures and associates during the period[74] Market and Industry Trends - The real estate investment in 2024 was 10.03 trillion RMB, down 10.6% year-on-year, indicating a challenging market environment[35] - The overall real estate market is anticipated to recover gradually, supported by government policies aimed at stabilizing the market[88] - The real estate market in Xi'an is expected to stabilize, with a projected 12% year-on-year decline in residential transaction area for 2024[88] Operational Strategies - The company implemented 209 optimization measures for cost control, resulting in a management expense savings of 27.42 million RMB compared to the budget[33] - The company plans to continue product innovation and standardization to meet evolving market demands and enhance customer experience[32] - The company is focusing on optimizing its operational strategies, including enhancing investment, product refinement, and risk management[91] Governance and Management - The company held 12 board meetings in 2024, reviewing 57 proposals, indicating active governance and decision-making processes[100] - The company organized multiple performance briefings throughout the year to enhance investor relations and improve information disclosure quality[101] - The total remuneration for directors and senior management during the reporting period amounted to 664.87 million yuan[104] - The company has a diverse board with independent directors and a mix of experienced professionals in key positions[104] Risk Management - The company has reported no significant risk events during the reporting period[6] - The company is committed to enhancing risk management systems to mitigate major risks and ensure brand safety[96] Employee and Training - The company reported a total of 781 employees, with 85 in the parent company and 696 in major subsidiaries[124] - The employee composition includes 288 sales personnel, 250 technical staff, 97 finance personnel, 112 administrative staff, and 34 others[124] - Training programs are in place, combining general and specialized training to enhance employee skills and support talent development[126] Environmental and Social Responsibility - The company actively promotes waste classification in residential areas, setting up centralized disposal points and implementing four-category waste classification standards[141] - The company encourages low-carbon practices in the office, such as turning off computers and air conditioning after hours, and promoting public transportation for commuting[143] Legal Matters - The company is currently involved in significant litigation matters, including a claim for 45 million yuan related to a cooperation agreement, with ongoing enforcement actions[151] - Another litigation involves a claim for 58.4974 million yuan for breach of a relocation compensation agreement, with a mediation agreement reached for repayment[151] Financing and Debt - The company issued bonds totaling 9 billion on December 30, 2021, with a coupon rate of 7.5%[167] - The company issued 10 billion in medium-term notes on February 6, 2024, with a coupon rate of 6%[167] - The total amount of guarantees provided to shareholders and related parties is included in the overall guarantee amount[160]

重庆万里新能源股份有限公司2025 年第一季度报告 证券代码：600847 证券简称：万里股份 重庆万里新能源股份有限公司 2025 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人莫天全、主管会计工作负责人刘仕钦及会计机构负责人（会计主管人员）杜正洪保证 季度报告中财务信息的真实、准确、完整。 第一季度财务报表是否经审计 □是√否 一、主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | | | 本报告期比上年同 | | | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期 期增减变动幅度 | | | | | (%) | | | 营业收入 | 123,804,706.09 | 123,528,340.30 | 0.22 | | 归属于上市公司股东的净利 | -9,083,793.73 ...

Financial Performance - The company's operating revenue for Q1 2025 was CNY 1,112,184,199.98, representing a 43.00% increase compared to CNY 777,734,696.76 in the same period last year[4]. - The net loss attributable to shareholders was CNY -34,871,267.83, an improvement from a loss of CNY -98,644,070.26 in the previous year[4]. - The net cash flow from operating activities was CNY 1,199,135,572.55, a significant recovery from a negative cash flow of CNY -171,019,746.43 in the same period last year[4]. - The weighted average return on equity improved to -0.22%, up by 0.42 percentage points from -0.64% in the previous year[5]. - The basic and diluted earnings per share were both CNY -0.01, unchanged from the previous year[4]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 43,426,407,310.59, a 1.96% increase from CNY 42,593,036,827.78 at the end of the previous year[5]. - The company's total equity decreased slightly to RMB 15.95 billion from RMB 15.99 billion, a decline of about 0.3%[15]. - Total liabilities increased to RMB 27.48 billion from RMB 26.60 billion, marking a rise of approximately 3.3%[15]. - The inventory level decreased to RMB 3.75 billion from RMB 4.69 billion, a reduction of approximately 19.8%[14]. - The long-term borrowings increased to RMB 9.49 billion from RMB 8.67 billion, reflecting a growth of about 9.5%[15]. - The company's short-term borrowings rose to RMB 2.17 billion from RMB 1.84 billion, an increase of approximately 18.0%[14]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 123,905[10]. - Jinko Solar Group Co., Ltd. held 23.90% of the shares, amounting to 853,400,000 shares, with 511,255,347 shares pledged[10]. - The company held 74,741,287 shares in its repurchase account, accounting for 2.09% of the total share capital[11]. Cash Flow Activities - The net cash inflow from investment activities was $163.41 million, a decrease from $227.08 million year-over-year[21]. - The net cash outflow from investment activities was $444.53 million, compared to $827.69 million in the previous period[21]. - Cash inflow from financing activities totaled $1.99 billion, an increase from $1.83 billion year-over-year[21]. - The net cash outflow from financing activities was $1.32 billion, down from $1.50 billion in the previous period[21]. - The net cash flow from financing activities was $676.29 million, compared to $324.85 million in the previous period[21]. - The cash and cash equivalents at the end of the period amounted to $5.96 billion, up from $2.99 billion year-over-year[21]. - The company received $1.54 billion in cash from borrowings, an increase from $1.20 billion in the previous period[21]. - The cash received from other financing activities was $455.50 million, down from $632.10 million year-over-year[21]. - The cash paid for debt repayment was $450.11 million, a decrease from $893.24 million in the previous period[21]. - The impact of exchange rate changes on cash and cash equivalents was $1.50 million, compared to a negative impact of $657.19 thousand in the previous period[21]. Government Subsidies and User Data - The company received government subsidies related to new energy totaling CNY 4,447,789.60, which are expected to have a lasting impact on profitability[7]. - The company reported a significant increase in user data from its household rolling development business, contributing positively to revenue growth[8].

Financial Performance - The company's operating revenue for Q1 2025 was CNY 257,418,265.66, a decrease of 23.51% compared to CNY 336,558,236.01 in the same period last year[5] - Net profit attributable to shareholders was CNY 2,761,438.28, down 78.21% from CNY 12,671,739.22 year-on-year[5] - Basic earnings per share decreased by 78.14% to CNY 0.0094 from CNY 0.0430 in the same period last year[5] - Total operating revenue for Q1 2025 was ¥257.42 million, a decrease of 23.4% compared to ¥336.56 million in Q1 2024[26] - Net profit for Q1 2025 was ¥1.23 million, a decline of 87.3% from ¥9.62 million in Q1 2024[27] - The total comprehensive income for Q1 2025 was ¥1.23 million, a significant drop from ¥9.63 million in Q1 2024[27] Cash Flow - The net cash flow from operating activities was negative CNY 4,350,064.43, a decline of 107.95% compared to CNY 54,745,928.03 in the previous year[5] - Operating cash flow for Q1 2025 was negative at -¥4.35 million, compared to positive cash flow of ¥54.75 million in Q1 2024[30] - Cash inflow from operating activities totaled 194,882,122.09, compared to 263,062,501.37 in the same period last year, indicating a decrease of about 26%[40] - Cash outflow from operating activities was 178,895,582.44, down from 224,010,554.00, reflecting a reduction of approximately 20%[40] - The cash flow from financing activities for Q1 2025 was CNY 61,692,723.15, a significant improvement from a net cash outflow of CNY 51,657,920.84 in Q1 2024[31] - The net cash flow from financing activities was 42,356,460.48, a significant improvement compared to -49,062,450.57 in the previous year[41] Assets and Liabilities - Total assets at the end of the reporting period were CNY 3,606,523,833.04, an increase of 2.33% from CNY 3,524,394,269.57 at the end of the previous year[6] - The company's total liabilities increased to ¥1.80 billion in 2025 from ¥1.72 billion in 2024, reflecting a growth of 4.5%[23] - The company's total current liabilities reached CNY 1,498,629,755.67, up from CNY 1,428,511,817.17, which is an increase of approximately 4.9%[22] - The company's total assets as of March 31, 2025, amounted to CNY 2,785,516,683.11, up from CNY 2,756,353,497.56 at the end of 2024[34] - The company's total liabilities increased to CNY 1,094,933,122.23 as of March 31, 2025, compared to CNY 1,067,369,267.77 at the end of 2024[34] Investments and Expenses - Research and development expenses for Q1 2025 were ¥9.33 million, an increase of 29.9% compared to ¥7.18 million in Q1 2024[26] - The company reported a decrease in sales expenses to ¥32.31 million in Q1 2025 from ¥81.07 million in Q1 2024, a reduction of 60.1%[26] - The company reported a decrease in operating costs to CNY 7,915,401.95 in Q1 2025 from CNY 8,838,734.50 in Q1 2024, reflecting a cost reduction strategy[37] - The company’s cash outflow from investment activities totaled CNY 24,556,560.71 in Q1 2025, compared to CNY 62,612,081.33 in Q1 2024, indicating a reduction in investment spending[31] Shareholder Information - The company had a total of 16,547 common shareholders at the end of the reporting period[10] - Total equity attributable to shareholders rose slightly to ¥1.66 billion in 2025 from ¥1.66 billion in 2024, indicating a marginal increase of 0.05%[23] Legal and Compliance - The company has several accounts frozen due to legal issues, with a total balance of CNY 379,986.58 in one account as of March 31, 2025, which may impact liquidity[17] - The company has not adopted new accounting standards or interpretations starting from 2025[41]

Financial Performance - The company's operating revenue for Q1 2025 was CNY 1,665,534,015.15, representing a year-on-year increase of 1.41% compared to CNY 1,642,316,571.66 in the same period last year[5] - Net profit attributable to shareholders of the listed company reached CNY 257,254,872.92, marking a 10.94% increase from CNY 231,882,725.65 in the previous year[5] - The net profit after deducting non-recurring gains and losses was CNY 236,035,912.02, which is a 6.64% increase from CNY 221,335,187.64 in the previous year[5] - Net profit for Q1 2025 was ¥260,324,032.70, representing a 6.5% increase from ¥244,033,825.90 in Q1 2024[21] - Basic earnings per share rose to CNY 0.26, a 4.00% increase from CNY 0.25 in the previous year[5] - Earnings per share for Q1 2025 were ¥0.26, compared to ¥0.25 in Q1 2024[21] - Diluted earnings per share increased by 4.17% to CNY 0.25, up from CNY 0.24 in the same period last year[5] Cash Flow and Investments - The net cash flow from operating activities increased by 37.40%, amounting to CNY 490,088,054.50, compared to CNY 356,677,090.96 in the same period last year[5] - Cash flow from operating activities for Q1 2025 was $490,088,054.50, an increase of 37.2% compared to $356,677,090.96 in Q1 2024[24] - Total cash inflow from investment activities in Q1 2025 was $1,320,359,362.82, significantly higher than $429,260,990.38 in Q1 2024[25] - Net cash flow from financing activities in Q1 2025 was $475,848,622.37, a decrease of 74.0% compared to $1,836,697,124.45 in Q1 2024[25] - The net increase in cash and cash equivalents for Q1 2025 was -$391,721,918.53, contrasting with a net increase of $1,618,392,325.56 in Q1 2024[25] - Cash received from the sale of goods and services in Q1 2025 was $1,791,847,186.23, up from $1,654,540,103.08 in Q1 2024, reflecting a growth of 8.3%[24] - Cash received from the recovery of investments in Q1 2025 was $1,312,993,920.50, a significant rise from $412,981,704.11 in Q1 2024[25] Assets and Liabilities - Total assets at the end of the reporting period were CNY 14,921,825,722.10, reflecting a 4.54% increase from CNY 14,274,215,359.32 at the end of the previous year[6] - The company's current assets decreased to RMB 6,479,414,193.94 from RMB 6,693,002,822.60, representing a decline of about 3.19%[15] - The total liabilities rose to RMB 5,095,021,716.17 from RMB 4,676,233,220.76, indicating an increase of approximately 8.99%[16] - The total liabilities increased to ¥6,146,882,949.73 in the current period from ¥5,769,343,382.09 in the previous period[20] - The company's total equity increased to RMB 9,826,804,005.93 from RMB 9,597,982,138.56, representing a growth of approximately 2.38%[16] - The total equity attributable to shareholders rose to ¥8,513,362,923.82 from ¥8,235,218,623.42 year-over-year[20] Other Financial Metrics - The weighted average return on net assets decreased by 0.34 percentage points to 3.09% compared to the previous year[6] - The company reported non-recurring gains totaling CNY 21,218,960.90 for the period[8] - Research and development expenses for Q1 2025 were ¥84,942,655.55, slightly higher than ¥83,108,956.73 in Q1 2024[20] - Other comprehensive income after tax for Q1 2025 was ¥3,616,021.19, compared to ¥2,956,210.66 in Q1 2024[21] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 33,390[10] Accounting Standards and Reporting - The company did not apply new accounting standards for the first time in 2025[26] - The board of directors announced the financial results on April 29, 2025[27]